Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment.
Giandomenico RovielloAndrea Casadei-GardiniStefania NobiliEnrico MiniSara FancelliPublished in: Journal of oncology (2020)
Future studies are awaited to define best candidates for novel agents approved in the second line of treatment for HCC.
Keyphrases